Lifecore Biomedical (LFCR) Return on Capital Employed: 2012-2025
Historic Return on Capital Employed for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to -0.08%.
- Lifecore Biomedical's Return on Capital Employed fell 4.00% to -0.08% in Q2 2025 from the same period last year, while for May 2025 it was -0.08%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.08% for FY2025, which is 4.00% down from last year.
- According to the latest figures from FY2025, Lifecore Biomedical's Return on Capital Employed is -0.08%, which was down 93.56% from -0.04% recorded in FY2024.
- Lifecore Biomedical's Return on Capital Employed's 5-year high stood at -0.03% during FY2021, with a 5-year trough of -0.10% in FY2023.
- In the last 3 years, Lifecore Biomedical's Return on Capital Employed had a median value of -0.08% in 2025 and averaged -0.07%.
- In the last 5 years, Lifecore Biomedical's Return on Capital Employed grew by 8bps in 2021 and then declined by 4bps in 2023.
- Yearly analysis of 5 years shows Lifecore Biomedical's Return on Capital Employed stood at -0.03% in 2021, then dropped by 3bps to -0.06% in 2022, then fell by 4bps to -0.10% in 2023, then climbed by 6bps to -0.04% in 2024, then declined by 4bps to -0.08% in 2025.